BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in ALXO — Alx Oncology Holdings Inc

CIK 1107261 HOUSTON, TX

Position in ALXO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$467,969

+$315,445 QoQ

Shares Held

226,072

+197.2% QoQ

Ownership

0.163%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#33

of 94 holders

Holding Since

Jun 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. ALXO ranks #42 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GLUE	Monte Rosa Therapeutics, Inc.	552,566	$13,372,097
2	INVA	Innoviva, Inc.	350,253	$7,954,245
3	PBYI	Puma Biotechnology, Inc.	791,616	$6,420,005
4	RIGL	Rigel Pharmaceuticals Inc	124,184	$4,858,078
5	EXEL	Exelixis, Inc.	66,100	$3,596,501
6	CRMD	CorMedix Inc.	434,132	$3,407,936
7	KROS	Keros Therapeutics, Inc.	265,017	$2,835,681
8	PTCT	Ptc Therapeutics, Inc.	22,000	$1,794,540

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$467,969	226,072	+197.2%	Shares	Sole	2026-08-14
2026-03-31	$152,524	76,072	0.0%	Shares	Sole	2026-05-15
2025-12-31	$85,961	76,072	+111.3%	Shares	Sole	2026-02-17
2025-09-30	$65,880	36,000	-52.0%	Shares	Sole	2025-11-14
2024-12-31	$125,250	75,000	+275.0%	Shares	Sole	2025-02-14
2024-03-31	$223,000	20,000	-40.3%	Shares	Sole	2024-05-15
2023-12-31	$498,815	33,500	-30.9%	Shares	Sole	2024-02-14
2023-09-30	$232,800	48,500	0.0%	Shares	Sole	2023-11-14
2023-06-30	$364,235	48,500	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.